The Latest Cardiac and Vascular News
Supira’s technology features a novel low profile, high continuous flow design that aims to provide full hemodynamic support for high-risk percutaneous coronary interventions (HRPCI) and cardiogenic shock (CS) patients with a single device Data from the Company’s First-in-Human trial to be presented as part of the Late-Breaking Clinical Research Session […]
— New Research Demonstrates Multifactorial Beneficial Effects of VASCEPA/VAZKEPA on Coronary Physiology and Plaque Progression — –Data Further Advances Understanding of VASCEPA/VAZKEPA Potential Mechanism of Action– DUBLIN, Ireland and BRIDGEWATER, N.J., May 12, 2023 (GLOBE NEWSWIRE) — Amarin Corporation plc (NASDAQ:AMRN) today highlighted new data describing the benefits of VASCEPA®/VAZKEPA® (icosapent […]
$100,000 prize awarded for Stanford Medicine’s AI solution for identifying people with heart attack risk LOS ANGELES, May 12, 2023 /PRNewswire/ — The UCLA Center for SMART Health, an interdisciplinary collaborative that looks to the integrated transformation of healthcare through emergent data and technologies, and Hearst Health, a division of Hearst and leader […]
State-of-the-art structural heart capabilities simplify pre-op planning for interventional clinicians through automated workflows and enhanced interoperability CAMBRIDGE, Mass., May 11, 2023 /PRNewswire/ — ConcertAI’s TeraRecon, the advanced visualization (AV) and clinical AI SaaS category leader, today announced the global launch of its flagship, best-in-KLAS advanced visualization product, Intuition 4.7. A dedicated structural heart […]
Doctor outlines key distinctions and how to respond to both conditions RAHWAY, N.J., May 10, 2023 /PRNewswire/ — The terms “heart attack” and “cardiac arrest” are often used interchangeably. In reality, they are distinct, typically with different causes and requiring different responses in the moment to get the person the help they […]
KUALA LUMPUR, Malaysia, May 11, 2023 /PRNewswire/ — In an effort to encourage people to take care of their heart health, Pfizer Malaysia is calling for Malaysians to learn more about transthyretin amyloid cardiomyopathy (ATTR-CM), a rare, life-threatening disease. ATTR-CM is caused by unstable transthyretin proteins that misfold and aggregate into amyloid […]
SALT LAKE CITY–(BUSINESS WIRE)–Foldax® Inc. today announced that it has executed an agreement with Australia’s national science agency, CSIRO, for full ownership of a polymer technology patent family. Foldax has incorporated the polymer technology into its LifePolymer™ materials platform and has conducted testing, which indicates the materials are compatible with blood, with […]
SHANGHAI, China and PRINCETON, N.J., May 11, 2023 (GLOBE NEWSWIRE) — LianBio (Nasdaq: LIAN), a biotechnology company dedicated to bringing innovative medicines to patients in China and other major Asian markets, today announced that CAMZYOS® (mavacamten) has received marketing approval for the treatment of adults with symptomatic obstructive hypertrophic cardiomyopathy (oHCM) from […]
Advancement of Additional Cardiac Myosin Inhibitor Expands Specialty Cardiovascular Portfolio SOUTH SAN FRANCISCO, Calif., May 11, 2023 (GLOBE NEWSWIRE) — Cytokinetics, Incorporated (Nasdaq: CYTK) today announced that the first participants have been dosed in a Phase 1 randomized, double-blind, placebo-controlled, multi-part, single and multiple ascending dose clinical study of CK-4021586 […]
CHICAGO–(BUSINESS WIRE)–Cardio Diagnostics Holdings, Inc (Nasdaq: CDIO), a precision cardiovascular medicine company, today announced a partnership with Connect Clinic to help MidWest/South Central self-insured employers build access to heart disease initiatives. These states lack ready access to precision heart disease technologies needed to tackle cardiovascular disease at scale while also having […]
